Moreover, elevation of pro-inflammatory T cell cytokine levels in the brains of PBS-treated hαSyn PD mice compared to EV controls such as IL-2, IL-4, IL-5, IL-13, IL-17, and IFN-γ were decreased after CD28SA treatment (Fig. 6E–J). This evidence concerns the gene IL13 and Parkinson disease.